Prime Medicine, Inc. - Common Stock — 貸借対照表 (NASDAQ:PRME) | MetaTrader

チャート全体を表示 Full chart

Financials

概要明細書統計配当金

総資産 360.31 M193.85 M297.51 M342.73 M 負債合計 44.04 M60.78 M144.36 M221.87 M 純資産合計 316.27 M133.07 M153.15 M120.87 M 負債および純資産合計 360.31 M193.85 M297.51 M342.73 M 有利子負債合計 ———— 純負債 ————

Prime Medicine, Inc. - Common Stock

Prime Medicine, Inc. is an American biotechnology company developing gene therapies based on prime editing. The company is headquartered in Cambridge, Massachusetts.

ニュース

Prime Medicine, Inc. (PRME) Reports Q1 Loss, Misses Revenue Estimates

RenovoRx, Inc. (RNXT) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release

Harmony Biosciences Holdings, Inc. (HRMY) Q1 Earnings and Revenues Miss Estimates

Prime Medicine, Inc. (PRME) Presents at TD Cowen 46th Annual Health Care Conference Transcript

Citizens、Prime Medicine株の投資判断を維持、PM359の規制経路を評価

Citizens reiterates Prime Medicine stock rating on PM359 pathway

Prime Medicine, Inc. (PRME) Reports Q4 Loss, Misses Revenue Estimates

Vanda Pharmaceuticals (VNDA) Reports Q4 Loss, Lags Revenue Estimates

プライム・ドリンク・グループ、非公開株式発行の第一次クロージングを完了

Prime Drink Group completes first closing of private placement

Prime: Maintaining "Buy" On Solidified Catalysts For Wilson's Disease And Beyond

プライム・ドリンク・グループ、最大500万ドルの資金調達に向け私募を発表